Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 3Brain Neoplasms 3Pancreatic Neoplasms 2Breast Neoplasms 2Warts 1Surgical Wound 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Skin Diseases 1Sarcoma 1Radiodermatitis 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Neuroinflammatory Diseases 1Melanoma 1Lung Neoplasms 1Locally Advanced Cervical Cancer 1Limited Stage Small Cell Lung Cancer 1Hypoxia 1Hemorrhage 1Hematologic Neoplasms 1Head and Neck Neoplasms 1Gastrointestinal Neoplasms 1Esophageal Neoplasms 1Atrial Fibrillation 1

Interventions

Fluorouracil 13pembrolizumab 12Paclitaxel 12Oxaliplatin 12Leucovorin 9Carboplatin 9Capecitabine 8Trastuzumab 7Nivolumab 7Cisplatin 7Radiotherapy 6Radiation 6Taxes 5Esophagectomy 5Drug Therapy 5Surgical Procedures, Operative 4Specimen Handling 4Irinotecan 4trastuzumab deruxtecan 3tislelizumab 3patritumab deruxtecan 3Radiotherapy, Intensity-Modulated 3Proton Therapy 3Immunotherapy 3zanidatamab 2ulixertinib 2trastuzumab biosimilar HLX02 2relatlimab 2durvalumab 2atezolizumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Esophageal Neoplasms × Sodium Chloride × 90 days × Clear all
NCT06067438 2026-05-22

Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal Cancer

OHSU Knight Cancer Institute

Phase 2 Recruiting
90 enrolled
Gastrointestinal

Atrial Fibrillation, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡